EBV INFECTION
Clinical trials for EBV INFECTION explained in plain language.
Never miss a new study
Get alerted when new EBV INFECTION trials appear
Sign up with your email to follow new studies for EBV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor cells take on Drug-Resistant viruses in new trial
Disease control Recruiting nowThis early-phase trial tests a treatment called LB-DTK-MV, which uses immune cells from a healthy donor to fight three viruses (CMV, BKV, and EBV) that have become resistant to standard antiviral drugs. The study includes 27 adults who have had a stem cell transplant or certain c…
Matched conditions: EBV INFECTION
Phase: PHASE1, PHASE2 • Sponsor: LucasBio • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Recruiting nowThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Matched conditions: EBV INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a safer drug replace standard antiviral for kidney transplant patients?
Disease control Recruiting nowThis study tests if valacyclovir works as well as valganciclovir to prevent CMV and EBV infections in kidney transplant patients. Valganciclovir can cause bone marrow suppression, a serious side effect. The study will enroll 80 kidney transplant recipients and monitor them for ne…
Matched conditions: EBV INFECTION
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Scientists seek tissue samples to unlock HIV and cancer mysteries
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and tissue samples from people with HIV, KSHV, or certain cancers to help researchers learn more about these diseases. Participants must be 18 or older and may have HIV, KSHV, or related conditions. No treatment is given; the goal is to gat…
Matched conditions: EBV INFECTION
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC